Last reviewed · How we verify
Metformin and Rosuvastatin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Metformin and Rosuvastatin (Metformin and Rosuvastatin) — Jeil Pharmaceutical Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Metformin and Rosuvastatin TARGET | Metformin and Rosuvastatin | Jeil Pharmaceutical Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Metformin and Rosuvastatin CI watch — RSS
- Metformin and Rosuvastatin CI watch — Atom
- Metformin and Rosuvastatin CI watch — JSON
- Metformin and Rosuvastatin alone — RSS
Cite this brief
Drug Landscape (2026). Metformin and Rosuvastatin — Competitive Intelligence Brief. https://druglandscape.com/ci/metformin-and-rosuvastatin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab